Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Erythrocyte Glucotoxicity Results in Vascular Inflammation

Author(s): Charalampos Papadopoulos*

Volume 22, Issue 9, 2022

Published on: 25 May, 2022

Page: [901 - 903] Pages: 3

DOI: 10.2174/1871530322666220430013334

conference banner
Next »
[1]
Jain, S.K.; McVie, R.; Duett, J.; Herbst, J.J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes, 1989, 38(12), 1539-1543.
[http://dx.doi.org/10.2337/diab.38.12.1539] [PMID: 2583378]
[2]
Morabito, R.; Remigante, A.; Spinelli, S.; Vitale, G.; Trichilo, V.; Loddo, S.; Marino, A. high glucose concentrations affect band 3 protein in human erythrocytes. Antioxidants, 2020, 9(5), 365.
[http://dx.doi.org/10.3390/antiox9050365]
[3]
Schwartz, R.S.; Madsen, J.W.; Rybicki, A.C.; Nagel, R.L. Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes, 1991, 40(6), 701-708.
[http://dx.doi.org/10.2337/diab.40.6.701] [PMID: 2040386]
[4]
Wang, Z.; Park, K.; Comer, F.; Hsieh-Wilson, L.C.; Saudek, C.D.; Hart, G.W. Site-specific GlcNAcylation of human erythrocyte proteins: Potential biomarker(s) for diabetes. Diabetes, 2009, 58(2), 309-317.
[http://dx.doi.org/10.2337/db08-0994] [PMID: 18984734]
[5]
Szabó, E.; Kulin, A.; Korányi, L.; Literáti-Nagy, B.; Cserepes, J.; Somogyi, A.; Sarkadi, B.; Várady, G. Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients. Sci. Rep., 2021, 11(1), 1-10.
[http://dx.doi.org/10.1038/s41598-021-82417-8]
[6]
Palomino-Schätzlein, M.; Lamas-Domingo, R.; Ciudin, A.; Gutiérrez-Carcedo, P.; Marés, R.; Aparicio-Gómez, C.; Hernández, C.; Simó, R.; Herance, J.R. A translational in vivo and in vitro metabolomic study reveals altered metabolic pathways in red blood cells of type 2 diabetes. J. Clin. Med., 2020, 9(6), 1619.
[http://dx.doi.org/10.3390/jcm9061619] [PMID: 32471219]
[7]
Whillier, S.; Raftos, J.E.; Kuchel, P.W. Glutathione synthesis by red blood cells in type 2 diabetes mellitus. Redox Rep., 2008, 13(6), 277-282.
[http://dx.doi.org/10.1179/135100008X309046] [PMID: 19017468]
[8]
Wautier, J.L.; Wautier, M.P.; Schmidt, A.M.; Anderson, G.M.; Hori, O.; Zoukourian, C.; Capron, L.; Chappey, O.; Yan, S.D.; Brett, J.; Guillausseau, P.J.; Stern, D. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA, 1994, 91(16), 7742-7746.
[http://dx.doi.org/10.1073/pnas.91.16.7742] [PMID: 8052654]
[9]
Turpin, C.; Catan, A.; Guerin-Dubourg, A.; Debussche, X.; Bravo, S.B.; Álvarez, E.; Van Den Elsen, J.; Meilhac, O.; Rondeau, P.; Bourdon, E. Enhanced oxidative stress and damage in glycated erythrocytes. PLoS One, 2020, 15(7), e0235335.
[http://dx.doi.org/10.1371/journal.pone.0235335] [PMID: 32628695]
[10]
Viskupicova, J.; Blaskovic, D.; Galiniak, S.; Soszyński, M.; Bartosz, G.; Horakova, L.; Sadowska-Bartosz, I. Effect of high glucose concentrations on human erythrocytes in vitro . Redox Biol., 2015, 5, 381-387.
[http://dx.doi.org/10.1016/j.redox.2015.06.011] [PMID: 26141922]
[11]
Zhou, Z.; Mahdi, A.; Tratsiakovich, Y.; Zahorán, S.; Kövamees, O.; Nordin, F.; Uribe Gonzalez, A.E.; Alvarsson, M.; Östenson, C.G.; Andersson, D.C.; Hedin, U.; Hermesz, E.; Lundberg, J.O.; Yang, J.; Pernow, J. Erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase i. J. Am. Coll. Cardiol., 2018, 72(7), 769-780.
[http://dx.doi.org/10.1016/j.jacc.2018.05.052] [PMID: 30092954]
[12]
Mahdi, A.; Tengbom, J.; Alvarsson, M.; Wernly, B.; Zhou, Z.; Pernow, J. Red blood cell peroxynitrite causes endothelial dysfunction in type 2 diabetes mellitus via arginase. Cells, 2020, 9(7), E1712.
[http://dx.doi.org/10.3390/cells9071712] [PMID: 32708826]
[13]
Catan, A.; Turpin, C.; Diotel, N.; Patche, J.; Guerin-Dubourg, A.; Debussche, X.; Bourdon, E.; Ah-You, N.; Le Moullec, N.; Besnard, M.; Veerapen, R.; Rondeau, P.; Meilhac, O. Aging and glycation promote erythrocyte phagocytosis by human endothelial cells: Potential impact in atherothrombosis under diabetic conditions. Atherosclerosis, 2019, 291, 87-98.
[http://dx.doi.org/10.1016/j.atherosclerosis.2019.10.015] [PMID: 31704555]
[14]
Mahdi, A.; Jiao, T.; Yang, J.; Kövamees, O.; Alvarsson, M.; von Heijne, M.; Zhou, Z.; Pernow, J. The effect of glycemic control on endothelial and cardiac dysfunction induced by red blood cells in type 2 diabetes. Front. Pharmacol., 2019, 10, 861.
[http://dx.doi.org/10.3389/fphar.2019.00861] [PMID: 31427970]
[15]
Mahdi, A.; Tratsiakovich, Y.; Tengbom, J.; Jiao, T.; Garib, L.; Alvarsson, M.; Yang, J.; Pernow, J.; Zhou, Z. Erythrocytes induce endothelial injury in type 2 diabetes through alteration of vascular purinergic signaling. Front. Pharmacol., 2020, 11, 603226.
[http://dx.doi.org/10.3389/fphar.2020.603226] [PMID: 33390992]
[16]
Zhou, Z.; Collado, A.; Sun, C.; Tratsiakovich, Y.; Mahdi, A.; Winter, H.; Chernogubova, E.; Seime, T.; Narayanan, S.; Jiao, T.; Jin, H.; Alvarsson, M.; Zheng, X.; Yang, J.; Hedin, U.; Catrina, S-B.; Maegdefessel, L.; Pernow, J. Downregulation of erythrocyte MiR-210 induces endothelial dysfunction in type 2 diabetes. Diabetes, 2021, db210093.
[http://dx.doi.org/10.2337/db21-0093] [PMID: 34753800]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy